# Japan Substance Abuse Treatment Market > Japan Substance Abuse Treatment Market Research Report By Type (Alcohol Dependence, Tobacco & Drug Abuse) and By End User (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 12.49% - **2024:** $ 341.25 Million - **2025:** $ 383.87 Million - **2035:** $ 1,245 Million - **Key Players:** Acadia Healthcare (US), American Addiction Centers (US), Caron Treatment Centers (US), Hazelden Betty Ford Foundation (US), Lifeworks (GB), Prominence Treatment Center (US), Recovery Centers of America (US), Sierra Tucson (US) **Report ID:** MRFR/HC/48612-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/japan-substance-abuse-treatment-market-50369 --- ## Market Summary ## **Japan Substance Abuse Treatment Market Overview** As per MRFR analysis, the Japan Substance Abuse Treatment Market Size was estimated at 243 (USD Million) in 2023.The Japan Substance Abuse Treatment Market Industry is expected to grow from 273(USD Million) in 2024 to 756 (USD Million) by 2035. The Japan Substance Abuse Treatment Market CAGR (growth rate) is expected to be around 9.702% during the forecast period (2025 - 2035). **Key Japan Substance Abuse Treatment Market Trends Highlighted** Societal attitudes and government programs are now shaping numerous notable developments in the Japan Substance Abuse Treatment Market. A major market driver is the growing awareness of mental health concerns running parallel to drug misuse. Encouraging people to get treatment instead of shying away under societal pressure, Japan's government has been aggressively trying to lower the stigma attached to addiction. Improving access to treatment programs and encouraging preventative actions have been mostly due to initiatives run by the Ministry of Health, Labour, and Welfare. Especially as Japan confronts demographic concerns, including an aging population more prone to mental health and drug misuse problems, chances in this sector keep arising. Tailored treatment programs that meet the particular requirements of older people are in increasing demand, which can be an area for growth and development. Moreover, the use of technology in treatment protocols, such as telemedicine and mobile apps, opens the door to giving assistance and resources to those without quick access to in-person treatments. Recent developments in Japan show a move towards comprehensive methods in drug misuse treatment. This means integrating alternative treatments such as mindfulness, counselling, and community support networks with conventional approaches. The focus on community participation shows a more general shift in society's perspective on drug misuse as a health problem needing cooperative solutions rather than a personal failure. Aiming for more efficiently customized and accessible solutions for people in need, these trends and possibilities will change the scene of drug addiction treatment in Japan as they evolve. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Japan Substance Abuse Treatment Market Drivers** **Rising Substance Abuse Rates in Japan** Japan has seen a significant increase in substance abuse cases over the years, with reports indicating a sharp rise in drug-related offenses and addiction. According to the National Police Agency of Japan, the number of drug-related offenses peaked at over 27,000 cases in 2020, marking a substantial increase compared to previous years. This rising trend is driving the Japan Substance Abuse Treatment Market Industry as the government is mandated to provide more resources for treatment and prevention programs. Organizations like the Japan Federation of Therapeutic Communities are playing a critical role in advocating for effective treatment options, leading to increased investment in rehabilitation centers and outpatient treatment services. The urgency to address these challenges is prompting policymakers to reevaluate their approach towards substance abuse, thus contributing significantly to market growth. **Government Initiatives and Policies** The Japanese government has enacted various policies aimed at combating substance abuse issues, thereby fostering growth in the Japan Substance Abuse Treatment Market Industry. The Comprehensive Anti-Drug Strategy was established to promote education, prevention, and treatment programs, allocating a budget of approximately 3.6 billion yen annually for these initiatives. This governmental investment emphasizes the need to create awareness and enhance treatment facilities, thereby propelling the market forward. Additionally, organizations such as the Ministry of Health, Labour and Welfare have expanded their efforts to increase the accessibility of treatment services, including mental health support options linked to substance abuse, enhancing the overall landscape of the industry. These proactive measures are crucial in addressing growing public health concerns and driving market potential. **Increased Awareness and Stigma Reduction** There has been a noticeable shift in societal attitudes towards substance abuse in Japan, where awareness campaigns and educational programs are increasingly reducing the stigma surrounding addiction. Recent surveys indicate that over 60% of the Japanese population now views addiction as a health issue rather than a moral failing, compared to only 40% five years ago. Organizations like the Japan Association of Psychiatric Rehabilitation are actively participating in outreach efforts, promoting the understanding of addiction as a treatable disease. This shift in public perception is equally contributing to the Japan Substance Abuse Treatment Market Industry’s growth as individuals are becoming more willing to seek help, facilitating an increase in the demand for various treatment services. The ongoing societal engagement and focus on mental health are fostering a more supportive environment for those affected by substance abuse. **Japan Substance Abuse Treatment Market Segment Insights** **Substance Abuse Treatment Market Type Insights** The Japan Substance Abuse Treatment Market is characterized by various types of treatment, reflecting the diverse challenges posed by substance abuse in the region. Alcohol Dependence remains a major concern, representing a significant portion of treatment cases. The nuances of Japanese culture, which often revolves around social drinking, create both challenges and opportunities for treatment solutions targeting alcohol-related issues. The stigma associated with seeking help for alcohol addiction in Japan leads to many individuals remaining untreated, which highlights the need for culturally sensitive treatment options that encourage individuals to seek help. Tobacco remains another critical focus within the Substance Abuse Treatment Market.  Despite efforts to reduce smoking rates through public health campaigns and regulations, a considerable segment of Japan's population continues to grapple with tobacco dependence. The government implements various initiatives to curtail tobacco use, indicating a significant push towards therapeutic services aimed at helping individuals quit smoking. Furthermore, available treatments have evolved to include both traditional counseling and modern pharmacological interventions, aiming to cater to the needs of various demographics.Similarly, Drug Abuse holds a significant place in treatment discussions within Japan. While the overall rates may be lower compared to some other nations, the impact and societal consequences of illicit drug use remain considerable.  The growing awareness of drug-related issues has led to increased public health initiatives focusing on prevention, education, and treatment. Therefore, encompassing a broad spectrum of therapeutic approaches and services is vital to address the various substances associated with drug abuse effectively.The segmentation of the Japan Substance Abuse Treatment Market by type not only reflects the multifaceted nature of substance dependence but also points to the necessity for tailored treatment modalities suited to various demographics and cultural sensibilities.  By improving access to supportive resources and treatment options, there is significant potential to enhance recovery rates across these categories, thereby fostering overall public health in Japan. The interplay between the types of substance abuse and the effectiveness of treatment strategies underscores the need for continuous adaptation and evolution within the industry, aiming to meet the changing landscape of substance abuse and dependence in Japan. $IMAGE2_HERE$ Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Substance Abuse Treatment Market End User Insights** The Japan Substance Abuse Treatment Market has shown significant growth potential, particularly within the End User segment, which comprises various treatment settings catering to individuals battling substance abuse. Outpatient Treatment Centers are critical in providing flexible care options, allowing patients to maintain their daily routines while receiving necessary therapy, thus playing an essential role in early intervention strategies. Residential Treatment Centers provide immersive support environments, crucial for individuals requiring structured recovery phases, and are particularly significant for addressing severe addiction cases.Inpatient Treatment Centers dominate by offering comprehensive care for patients with acute needs, ensuring constant monitoring and a controlled environment that fosters recovery.  The increasing acknowledgment of mental health, alongside rising substance abuse rates in Japan, propels demand for these diverse treatment facilities. As societal stigma lessens, opportunities for expansion and innovative treatment methods emerge, emphasizing the need for a tailored approach in addressing the complexities of substance abuse in the region. This multifaceted approach reflects a broader awareness of the importance of personalized care in the rehabilitation process, ultimately contributing to improved patient outcomes in Japan. **Japan Substance Abuse Treatment Market Key Players and Competitive Insights** The Japan Substance Abuse Treatment Market is steadily gaining prominence due to the increasing recognition of substance abuse as a public health issue within the region. With rising prevalence rates of addiction to alcohol, prescription medications, and illicit drugs, effective treatment options have become a crucial need for individuals and communities alike. The competitive landscape is characterized by a mix of established pharmaceutical manufacturers, specialized addiction treatment centers, and innovative healthcare providers. As stakeholders within this market adapt to changing consumer demands for more holistic and personalized care approaches, they also face challenges related to regulatory frameworks, evolving treatment methodologies, and a need for public education on substance abuse. This combination of factors creates a dynamic environment wherein companies strive to differentiate themselves through innovative therapeutic solutions and effective outreach strategies. Otsuka Pharmaceutical has positioned itself as a pivotal player in the Japan Substance Abuse Treatment Market due to its commitment to improving mental health and treating addiction disorders. The company's focus on research and development enables it to offer a range of advanced treatment options, including pharmacotherapy for patients grappling with substance use disorders. With a strong emphasis on patient-centric approaches, Otsuka Pharmaceutical has built a solid reputation for its innovative contributions to the market, particularly in the realm of behavioral health. This strength is further bolstered by collaboration with healthcare professionals and community outreach initiatives aimed at raising awareness about treatment options available for substance abuse. The company's robust distribution network within Japan enhances its market presence, allowing it to cater effectively to healthcare institutions and patients seeking reliable treatment solutions.Kirin Holdings plays a significant role in the Japan Substance Abuse Treatment Market, leveraging its extensive experience in the healthcare sector to address the growing need for comprehensive substance abuse solutions. The company offers key products and services that focus on rehabilitation and support, primarily targeting alcohol addiction treatment, a pressing concern in Japan.  Kirin Holdings' strengths lie in its well-established market presence, strategic partnerships with healthcare professionals, and commitment to advancing treatment methodologies that combine traditional and innovative practices. The company actively engages in mergers and acquisitions to enhance its capabilities and expand its service offerings, ensuring that it stays abreast of evolving market demands. With a focus on both prevention and treatment, Kirin Holdings continues to invest in research and development initiatives aimed at fostering a deeper understanding of substance abuse issues and developing effective interventions tailored to the unique needs of the Japanese population. **Key Companies in the Japan Substance Abuse Treatment Market Include:** - Otsuka Pharmaceutical - Kirin Holdings - Johnson & Johnson - Daiichi Sankyo - Mitsubishi Tanabe Pharma - Roche - BristolMyers Squibb - Eisai - Takeda Pharmaceutical - Sanofi - AbbVie - Astellas Pharma - Gilead Sciences - Pfizer - Shionogi **Japan Substance Abuse Treatment Market Industry Developments** In recent developments within the Japan Substance Abuse Treatment Market, significant strides have been observed in the enhancement of treatment protocols and increased investments by leading pharmaceutical companies. Otsuka Pharmaceutical has been focusing on innovative therapeutic solutions, while Astellas Pharma is notably enhancing their research capabilities in addiction treatment.  As of October 2023, Kirin Holdings has announced a partnership aimed at exploring the role of nutrition in substance abuse recovery. Recent financial analysis indicates a steady growth in market valuation, driven by increasing awareness and the government's efforts to combat substance abuse, which include funding for treatment programs and facilities.  Notably, in September 2023, Daiichi Sankyo disclosed a strategic acquisition focused on bolstering their portfolio in the behavioral health segment, reflecting a wider trend of consolidation among key players like Mitsubishi Tanabe Pharma and Bristol Myers Squibb, who are seeking to expand their capabilities in this critical therapeutic area. The market's overall landscape continues to evolve as evidence-based practices gain traction, supported by a more robust regulatory environment focused on effective interventions and sustainable recovery outcomes. **Japan Substance Abuse Treatment Market Segmentation Insights** **Substance Abuse Treatment Market Type Outlook** - Alcohol Dependence - Tobacco & Drug Abuse **Substance Abuse Treatment Market End User Outlook** - Outpatient Treatment Centers - Residential Treatment Centers - Inpatient Treatment Centers ## Market Drivers ### Government Initiatives and Funding Government initiatives aimed at combating substance abuse are pivotal in shaping the substance abuse-treatment market. The Japanese government has allocated substantial funding to enhance treatment facilities and support programs. In recent years, the budget for addiction treatment services has increased by over 20%, reflecting a commitment to addressing this pressing issue. These initiatives not only improve access to treatment but also promote the development of innovative therapeutic approaches. As a result, the substance abuse-treatment market is likely to experience growth driven by enhanced resources and support from governmental bodies. ### Advancements in Treatment Modalities Advancements in treatment modalities are significantly influencing the substance abuse-treatment market. Innovative therapies, including pharmacological treatments and behavioral therapies, are being developed and implemented in Japan. These advancements not only improve treatment outcomes but also attract individuals who may have previously been reluctant to seek help. The introduction of new medications and therapeutic techniques has the potential to enhance recovery rates, thereby expanding the market. As the effectiveness of these modalities becomes more widely recognized, the substance abuse-treatment market is likely to see increased demand for diverse treatment options. ### Rising Incidence of Substance Abuse Disorders The rising incidence of substance abuse disorders in Japan is a critical driver for the substance abuse-treatment market. Recent data indicates that the prevalence of addiction has increased by approximately 15% over the past five years, prompting a need for more comprehensive treatment solutions. This trend is likely to result in a greater demand for various treatment services, including inpatient and outpatient care. As the number of individuals affected by substance abuse continues to grow, the substance abuse-treatment market is expected to expand significantly, necessitating the development of more effective and accessible treatment options. ### Increasing Awareness of Substance Abuse Issues The growing awareness of substance abuse issues in Japan is a crucial driver for the substance abuse-treatment market. Public campaigns and educational programs have been implemented to inform citizens about the dangers of addiction. This heightened awareness has led to an increase in individuals seeking treatment, thereby expanding the market. According to recent statistics, approximately 30% of the population acknowledges substance abuse as a significant societal problem. This recognition is likely to foster a more supportive environment for those in need of treatment, ultimately driving demand for various therapeutic services and interventions within the substance abuse-treatment market. ### Cultural Shifts Towards Acceptance of Treatment Cultural shifts in Japan are gradually changing perceptions surrounding substance abuse and its treatment. Historically, stigma has hindered individuals from seeking help, but recent trends indicate a move towards greater acceptance of treatment options. This evolving mindset is likely to encourage more individuals to pursue assistance, thereby expanding the substance abuse-treatment market. Surveys suggest that around 40% of respondents now view seeking help for addiction as a positive step, which could lead to increased utilization of treatment services and a more robust market landscape. ## Future Outlook The [Substance Abuse Treatment Market](https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230) is projected to grow at a 12.49% CAGR from 2025 to 2035, driven by increasing awareness, technological advancements, and policy support. **New opportunities:** - Expansion of telehealth services for remote patient monitoring. - Development of personalized treatment plans using AI analytics. - Investment in community-based rehabilitation programs to enhance accessibility. By 2035, the market is expected to achieve substantial growth, driven by innovative treatment solutions and increased demand. ## Segment Insights ### By Type: Alcohol Dependence (Largest) vs. Tobacco & Drug Abuse (Fastest-Growing) In the Japan substance abuse-treatment market, Alcohol Dependence dominates the segment distribution, holding a significant share, while Tobacco & Drug Abuse is on the rise, attracting attention due to its rapid growth. This contrast highlights the evolving landscape of substance abuse in the region, with Alcohol Dependence maintaining a stronghold despite emerging trends in drug abuse treatment. The growth trends in this segment are primarily driven by increased awareness and the introduction of comprehensive treatment programs for both Alcohol Dependence and Tobacco & Drug Abuse. Government initiatives and public health campaigns play a pivotal role in fostering a supportive environment for treatment. Factors such as changing societal attitudes towards addiction, accessibility of treatment options, and enhanced support systems are expected to propel growth, particularly in the Tobacco & Drug Abuse category. Alcohol Dependence (Dominant) vs. Tobacco & Drug Abuse (Emerging) Alcohol Dependence remains the dominant segment in the Japan substance abuse-treatment market, characterized by well-established treatment protocols and a robust network of support services. This segment benefits from a long history of public and medical recognition, leading to various treatment modalities being available, including rehabilitation programs and counseling services. Conversely, Tobacco & Drug Abuse is emerging as a significant focus, spurred by rising awareness of its health impacts and social stigma reduction. This segment is attracting more investment and development of targeted treatments, indicating a shift in treatment priorities and a growing recognition of different substance abuses that require specialized solutions. ### By End User: Outpatient Treatment Centers (Largest) vs. Residential Treatment Centers (Fastest-Growing) In the Japan substance abuse-treatment market, the distribution of market share among treatment types reveals that outpatient treatment centers hold the largest portion. This dominance can be attributed to their accessibility and flexibility for patients, allowing individuals to receive care while maintaining their daily routines. Conversely, residential treatment centers, although smaller in share, are rapidly gaining traction as more people recognize the need for intensive support, leading to significant growth in this segment. The growth trends in this segment indicate a shift towards more personalized and community-based care options. Outpatient treatment centers are benefitting from advancements in telehealth services, making treatment more accessible. Meanwhile, residential treatment centers are emerging due to growing awareness of the effectiveness of immersive recovery environments. Factors such as increasing substance abuse awareness and changes in societal attitudes are driving this growth, contributing to the evolving dynamics of the market. Outpatient Treatment Centers (Dominant) vs. Residential Treatment Centers (Emerging) Outpatient treatment centers are characterized by their ability to provide flexible treatment options, allowing patients to engage in therapy while continuing their daily activities. These centers are often preferred by those seeking a less disruptive recovery process, as they offer supportive services without the need for prolonged stays. In contrast, residential treatment centers focus on providing an immersive environment for recovery, catering to individuals requiring intensive therapy and supervision. These centers are increasingly recognized for their role in addressing complex cases of substance abuse. As societal attitudes shift and more resources are allocated to mental health interventions, both segments are poised for growth, with outpatient centers maintaining dominance and residential centers emerging as key contributors to treatment innovations. ## Competitive Benchmarking The substance abuse-treatment market in Japan is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on digital transformation. Key players such as Acadia Healthcare (US), American Addiction Centers (US), and Hazelden Betty Ford Foundation (US) are actively positioning themselves to capture market share through various strategic initiatives. Acadia Healthcare (US), for instance, emphasizes a comprehensive approach to treatment, integrating evidence-based practices with a focus on patient-centered care. This strategy not only enhances their service offerings but also strengthens their competitive edge in a market that values holistic treatment methodologies.The market structure appears moderately fragmented, with a mix of established players and emerging treatment centers. Companies are adopting key business tactics such as localizing services to better meet the needs of Japanese clients and optimizing their supply chains to ensure efficient service delivery. This collective influence of major players fosters a competitive environment where innovation and quality of care are paramount, potentially leading to improved patient outcomes and satisfaction. In October American Addiction Centers (US) announced a strategic partnership with a leading telehealth provider to enhance their digital service offerings. This move is significant as it aligns with the growing trend of integrating technology into treatment protocols, allowing for more accessible care options for patients. By leveraging telehealth, the company aims to reach a broader audience, particularly those in remote areas, thereby expanding its market presence and improving treatment accessibility. In September Hazelden Betty Ford Foundation (US) launched a new initiative focused on community outreach and education regarding substance abuse. This initiative is crucial as it not only raises awareness but also positions the foundation as a thought leader in the field. By engaging with local communities, the foundation seeks to destigmatize addiction and promote early intervention, which could lead to a more informed public and potentially lower rates of substance abuse in the long term. In August Caron Treatment Centers (US) expanded its operations by opening a new facility in Tokyo, aimed at providing culturally sensitive treatment options. This expansion reflects a strategic focus on regional growth and the importance of tailoring services to meet local needs. By establishing a presence in Japan, Caron Treatment Centers (US) is likely to enhance its competitive positioning and cater to the unique challenges faced by Japanese individuals struggling with substance abuse. As of November current trends in the substance abuse-treatment market indicate a strong shift towards digitalization, sustainability, and the integration of artificial intelligence in treatment protocols. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise to enhance service delivery. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technology, and the reliability of supply chains. This evolution suggests that companies that prioritize these aspects will likely emerge as leaders in the market. ## Recent News & Developments In recent developments within the Japan Substance Abuse Treatment Market, significant strides have been observed in the enhancement of treatment protocols and increased investments by leading pharmaceutical companies. Otsuka Pharmaceutical has been focusing on innovative therapeutic solutions, while Astellas Pharma is notably enhancing their research capabilities in addiction treatment.  As of October 2023, Kirin Holdings has announced a partnership aimed at exploring the role of nutrition in substance abuse recovery. Recent financial analysis indicates a steady growth in market valuation, driven by increasing awareness and the government's efforts to combat substance abuse, which include funding for treatment programs and facilities.  Notably, in September 2023, Daiichi Sankyo disclosed a strategic acquisition focused on bolstering their portfolio in the behavioral health segment, reflecting a wider trend of consolidation among key players like Mitsubishi Tanabe Pharma and Bristol Myers Squibb, who are seeking to expand their capabilities in this critical therapeutic area. The market's overall landscape continues to evolve as evidence-based practices gain traction, supported by a more robust regulatory environment focused on effective interventions and sustainable recovery outcomes. ## Report Scope | MARKET SIZE 2024 | 341.25(USD Million) | | --- | --- | | MARKET SIZE 2025 | 383.87(USD Million) | | MARKET SIZE 2035 | 1245.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.49% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Acadia Healthcare (US), American Addiction Centers (US), Caron Treatment Centers (US), Hazelden Betty Ford Foundation (US), Lifeworks (GB), Prominence Treatment Center (US), Recovery Centers of America (US), Sierra Tucson (US) | | Segments Covered | Type, End User | | Key Market Opportunities | Integration of telehealth services enhances accessibility in the substance abuse-treatment market. | | Key Market Dynamics | Rising demand for personalized treatment approaches in substance abuse-treatment, driven by evolving consumer preferences and regulatory support. | | Countries Covered | Japan | ## Frequently Asked Questions **Q: What was the market valuation of the Japan substance abuse-treatment market in 2024?** A: The market valuation was 341.25 USD Million in 2024. **Q: What is the projected market valuation for the Japan substance abuse-treatment market by 2035?** A: The projected valuation for 2035 is 1245.0 USD Million. **Q: What is the expected CAGR for the Japan substance abuse-treatment market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 12.49%. **Q: Which segments are included in the Japan substance abuse-treatment market?** A: The segments include Alcohol Dependence and Tobacco & Drug Abuse. **Q: What were the market values for Alcohol Dependence and Tobacco & Drug Abuse in 2024?** A: In 2024, Alcohol Dependence was valued at 136.5 USD Million, while Tobacco & Drug Abuse was valued at 204.75 USD Million. **Q: What are the projected market values for Alcohol Dependence and Tobacco & Drug Abuse by 2035?** A: By 2035, Alcohol Dependence is projected to reach 490.0 USD Million, and Tobacco & Drug Abuse is expected to reach 755.0 USD Million. **Q: What types of treatment centers are included in the end-user segments of the market?** A: The end-user segments include Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers. **Q: What were the market values for different types of treatment centers in 2024?** A: In 2024, Outpatient Treatment Centers were valued at 85.0 USD Million, Residential Treatment Centers at 100.0 USD Million, and Inpatient Treatment Centers at 156.25 USD Million. **Q: What are the projected market values for treatment centers by 2035?** A: By 2035, Outpatient Treatment Centers are projected to reach 300.0 USD Million, Residential Treatment Centers 400.0 USD Million, and Inpatient Treatment Centers 545.0 USD Million. **Q: Who are the key players in the Japan substance abuse-treatment market?** A: Key players include Acadia Healthcare, American Addiction Centers, Caron Treatment Centers, Hazelden Betty Ford Foundation, Lifeworks, Prominence Treatment Center, Recovery Centers of America, and Sierra Tucson. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/japan-substance-abuse-treatment-market-50369*